相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Jagged-1 juxtamembrane region: Biochemical characterization and cleavage by ADAM17 (TACE) catalytic domain
Maristella Coglievina et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
N. J. Shimwell et al.
BRITISH JOURNAL OF CANCER (2013)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Combinations of Urinary Biomarkers for Surveillance of Patients with Incident Nonmuscle Invasive Bladder Cancer: The European FP7 UROMOL Project
Tahlita C. M. Zuiverloon et al.
JOURNAL OF UROLOGY (2013)
EpCAM regulates cell cycle progression via control of cyclin D1 expression
A. Chaves-Perez et al.
ONCOGENE (2013)
An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
S. Miah et al.
BRITISH JOURNAL OF CANCER (2012)
Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
Nicholas D. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Urinary BTA: indicator of bladder cancer or of hematuria
Makito Miyake et al.
WORLD JOURNAL OF UROLOGY (2012)
Influencing factors on the NMP-22 urine assay: an experimental model
Makito Miyake et al.
BMC UROLOGY (2012)
Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Thomas Reinert et al.
CLINICAL CANCER RESEARCH (2011)
Urine Markers for Detection and Surveillance of Non-Muscle-Invasive Bladder Cancer
Derya Tilki et al.
EUROPEAN UROLOGY (2011)
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
Arnulf Stenzl et al.
EUROPEAN UROLOGY (2011)
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2011)
Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110
Silke Petsch et al.
MABS (2011)
Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria
Joerg Hennenlotter et al.
ADVANCES IN UROLOGY (2011)
The West Midlands Bladder Cancer Prognosis Programme: rationale and design
Maurice P. Zeegers et al.
BJU INTERNATIONAL (2010)
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
G. Mowatt et al.
HEALTH TECHNOLOGY ASSESSMENT (2010)
Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer
Takatsugu Okegawa et al.
INTERNATIONAL JOURNAL OF UROLOGY (2010)
Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
Ranju Ralhan et al.
PLOS ONE (2010)
Cell Discohesion and Multifocality of Carcinoma In situ of the Bladder: New Insight From the Adhesion Molecule Profile (e-Cadherin, Ep-CAM, and MUC1)
Carlo Patriarca et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
The present and future burden of urinary bladder cancer in the world
Martine Ploeg et al.
WORLD JOURNAL OF UROLOGY (2009)
EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder
A. Brunner et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients
H Abe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM)
JM Chong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
